Posted by Peter on 5-15 3:31 am
Tags: 2013 no-payment pledge, allow payments once again, competitive disadvantage, first in the industry, GlaxoSmithKline, key opinion leaders, other prescribing physicians, paying doctors for promoting its drugs, permit payments to global experts, product’s lifecycle, promote the benefits of their products, restricted time periods, scandals over sales practices, science behind novel new medicines, select number of innovative products
Categories:
General
Market
The Industry
